Profile data is unavailable for this security.
About the company
Kubota Pharmaceutical Holdings Co., Ltd. is a Japan-based company mainly engaged in the operation and management of subsidiaries. Its subsidiaries are mainly engaged in discovering and developing drug candidates to treat and slow the progression of sight-threatening ophthalmic diseases. The Company operates pharmaceutical development segment. It focuses on the development of oral formulation for age-related macular degeneration (AMD), glaucoma and dry eye syndrome.
- Revenue in JPY (TTM)39.74m
- Net income in JPY-1.39bn
- Incorporated2015
- Employees12.00
- LocationKubota Pharmaceutical Holdings Co Ltd1-15-37, Minami-AoyamaMINATO-KU 107-0062JapanJPN
- Phone+81 365508928
- Fax+81 365508929
- Websitehttps://www.kubotaholdings.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D.Western Therapeutics Institute Inc | 443.18m | -1.04bn | 2.78bn | 21.00 | -- | 2.88 | -- | 6.26 | -32.29 | -32.29 | 13.84 | 29.84 | 0.1784 | 0.472 | 3.10 | 21,103,950.00 | -42.16 | -13.06 | -45.11 | -14.36 | 91.32 | 94.29 | -236.36 | -72.51 | 11.65 | -- | 0.509 | -- | -4.40 | 7.90 | -89.07 | -- | 7.08 | -- |
| Muromachi Chemicals Inc | 6.12bn | 216.69m | 3.01bn | 205.00 | 13.75 | 1.39 | 8.57 | 0.4917 | 53.45 | 53.45 | 1,503.34 | 527.87 | 1.20 | 3.83 | 3.75 | 29,862,370.00 | 4.23 | -- | 6.84 | -- | 28.31 | -- | 3.54 | -- | 1.45 | 26.20 | 0.4483 | -- | 10.74 | -- | -43.83 | -- | -- | -- |
| Ribomic Inc | 0.00 | -1.02bn | 3.07bn | 25.00 | -- | 0.8917 | -- | -- | -28.70 | -28.70 | 0.00 | 94.20 | 0.00 | -- | -- | -- | -25.19 | -30.52 | -26.34 | -31.71 | -- | -- | -- | -1,777.84 | 22.49 | -- | -- | -- | -100.00 | -- | 38.04 | -- | 4.42 | -- |
| Atect Corp | 3.18bn | -244.35m | 3.22bn | 96.00 | -- | 1.82 | 9.32 | 1.01 | -55.27 | -55.27 | 718.38 | 398.84 | 0.5895 | 3.30 | 6.85 | -- | -4.54 | 0.7132 | -6.41 | 0.9718 | 43.40 | 47.04 | -7.69 | 1.32 | 0.6992 | -- | 0.5902 | 84.76 | 7.23 | 1.45 | -253.71 | -- | -23.49 | 0.00 |
| Human Metabolome Technologies Inc | 1.34bn | 285.75m | 3.83bn | 57.00 | 13.41 | 1.99 | 10.36 | 2.86 | 48.31 | 48.31 | 226.62 | 326.17 | 0.5643 | 17.82 | 3.80 | 23,500,000.00 | 12.04 | -- | 15.43 | -- | 63.89 | -- | 21.33 | -- | 3.84 | 124.76 | 0.1061 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 39.74m | -1.39bn | 3.94bn | 12.00 | -- | 1.68 | -- | 99.16 | -24.82 | -24.82 | 0.711 | 41.58 | 0.0118 | 0.3815 | 26.89 | 3,312,000.00 | -41.32 | -36.51 | -45.53 | -39.47 | 72.88 | -- | -3,492.38 | -13,528.87 | 8.97 | -- | 0.0555 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| Kringle Pharma Inc | 77.93m | -904.81m | 4.02bn | 13.00 | -- | 1.71 | -- | 51.53 | -159.92 | -159.92 | 13.58 | 356.64 | 0.027 | -- | 2.80 | 5,994,308.00 | -31.29 | -19.00 | -33.20 | -20.23 | -- | -- | -1,161.12 | -156.51 | 12.85 | -- | 0.00 | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| FunPep Co Ltd | 676.00k | -760.40m | 4.08bn | 15.00 | -- | 1.73 | -- | 6,040.51 | -31.52 | -31.52 | 0.028 | 90.56 | 0.0002 | -- | 3.39 | 45,066.67 | -26.86 | -27.10 | -28.42 | -28.75 | -- | -- | -112,484.90 | -815.82 | 17.27 | -1,006.15 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| BrightPath Biotherapeutics Co Ltd | 72.00k | -1.17bn | 4.11bn | 32.00 | -- | 4.19 | -- | 57,147.16 | -18.30 | -18.30 | 0.0011 | 13.84 | 0.00005 | -- | 2.36 | -- | -79.69 | -51.56 | -87.69 | -54.32 | 75.00 | 68.63 | -1,622,336.00 | -22,321.82 | -- | -435.39 | 0.1031 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
| Perseus Proteomics Inc | 100.40m | -1.10bn | 4.18bn | 24.00 | -- | 2.73 | -- | 41.60 | -93.74 | -93.74 | 8.52 | 117.15 | 0.0471 | 3.35 | 8.55 | -- | -51.85 | -41.34 | -54.94 | -43.43 | 87.33 | 91.72 | -1,100.04 | -891.26 | 12.77 | -- | -- | -- | 6.58 | -18.31 | -40.34 | -- | 60.30 | -- |
| Delta-Fly Pharma Inc | 0.00 | -1.43bn | 4.25bn | 11.00 | -- | 3.45 | -- | -- | -197.24 | -197.24 | 0.00 | 149.78 | 0.00 | -- | -- | -- | -120.07 | -67.70 | -141.25 | -72.02 | -- | -- | -- | -- | -- | -243.15 | -- | -- | -- | -- | -7.57 | -- | -9.04 | -- |
| Renascience Inc | 194.17m | -258.34m | 4.61bn | 3.00 | -- | 2.87 | -- | 23.77 | -20.32 | -20.32 | 15.27 | 126.40 | 0.089 | -- | -- | -- | -11.84 | -- | -12.49 | -- | 85.31 | -- | -133.05 | -- | -- | -- | 0.1814 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
| Immuno-Biological Laboratories Co., Ltd. | 816.70m | 186.69m | 4.65bn | 60.00 | 24.89 | 3.67 | -- | 5.69 | 20.05 | 20.05 | 87.69 | 135.86 | 0.535 | 0.9358 | 4.53 | -- | 12.23 | -13.97 | 14.68 | -16.39 | 63.34 | 57.73 | 22.86 | -39.23 | 3.65 | -- | 0.1572 | -- | 2.78 | 0.8924 | 164.44 | -- | -- | -- |
| Kidswell Bio Corp | 2.43bn | -1.42bn | 4.84bn | 41.00 | -- | 5.76 | -- | 1.99 | -40.81 | -40.81 | 68.79 | 21.35 | 0.5415 | 1.84 | 2.47 | -- | -31.67 | -57.41 | -51.25 | -81.13 | 42.75 | 55.20 | -58.49 | -123.52 | 1.70 | -28.91 | 0.7559 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 5.06bn | 637.97m | 5.20bn | 144.00 | 7.48 | 0.7669 | 6.87 | 1.03 | 152.41 | 152.41 | 1,206.78 | 1,486.43 | 0.6053 | 3.08 | 4.55 | -- | 7.64 | 6.92 | 9.96 | 9.26 | 50.46 | 51.84 | 12.62 | 10.80 | 2.43 | -- | 0.1221 | 18.46 | 2.71 | 1.60 | 12.28 | 10.57 | -9.83 | 16.36 |
| Solasia Pharma KK | 408.00m | -1.18bn | 5.22bn | 24.00 | -- | 2.70 | -- | 12.80 | -6.96 | -6.96 | 2.40 | 10.01 | 0.1432 | 2.01 | 3.06 | 17,000,000.00 | -41.50 | -48.57 | -53.67 | -58.83 | 51.23 | 71.01 | -289.71 | -300.89 | 1.68 | -400.00 | 0.2327 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
Data as of May 24 2024. Currency figures normalised to Kubota Pharmaceutical Holdings Co Ltd's reporting currency: Japanese Yen JPY
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Commons Asset Management, Inc.as of 19 Dec 2022 | 0.00 | 0.00% |
Data from 18 Jan 2023 - 18 Jan 2023Source: FactSet Research Systems Inc.
